SCHEMBL6492940

SCHEMBL6492940

CN(CC(O)CO)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
RXFP1 Q9HBX9 1/20 0.42
KDM1A O60341 1/20 0.42
POLB P06746 1/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
AOC3 Q16853 1/20 0.40
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
ALDH1A1 P00352 1/20 0.38
FAAH O00519 1/20 0.38
PHGDH O43175 1/20 0.38
MGLL Q99685 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNA5 P22460 1/20 0.38
KCNJ5 P48544 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11504772 0.84 KDM4E (0.45) KDM4EL3MBTL1RXFP1KDM1APOLB
SCHEMBL11741694 0.82 KDM4E (0.44) KDM4EL3MBTL1RXFP1KDM1APOLB
SCHEMBL8857146 0.82 SLC6A2 (0.49) KDM4EL3MBTL1RXFP1KDM1APOLB
SCHEMBL8632555 0.82 ALDH1A1 (0.41) KDM4EL3MBTL1SLC6A2SLC6A4ALDH1A1
SCHEMBL8852755 0.81 KDM4E (0.44) KDM4EL3MBTL1RXFP1KDM1APOLB
SCHEMBL11675414 0.81 KDM4E (0.42) KDM4EL3MBTL1RXFP1KDM1APOLB
SCHEMBL12932623 0.81 AOC3 (0.55) KDM4EL3MBTL1RXFP1KDM1APOLB
SCHEMBL11701688 0.81 AOC3 (0.44) KDM4EL3MBTL1RXFP1KDM1APOLB
SCHEMBL9100854 0.80 CETP (0.45) KDM4EL3MBTL1AOC3SLC6A2SLC6A4
SCHEMBL17453164 0.79 MMP12 (0.42) KDM4EL3MBTL1RXFP1KDM1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12257330-B2 Hair coloring compositions and methods of use L'OREAL (FR) 2025-03-25 US disclosed
WO-2005003140-A1 4-OXO-4,7-DIHYDROTHIENO[2,3-B]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2005-01-13 WO disclosed
US-20050004161-A1 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents AGOURON PHARMACEUTICALS, INC. 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004161-A1 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents ZC3HAV1, IRF3, BRD4 KDM4E 40/4885L3MBTL1 1342/4885RXFP1 2452/4885
US-12257330-B2 Hair coloring compositions and methods of use SGMS1, PHOSPHO1, SGMS2 KDM4E 3783/4885L3MBTL1 4412/4885RXFP1 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.